Literature DB >> 29461891

Pathophysiology of Chronic Systolic Heart Failure. A View from the Periphery.

Stuart D Katz1.   

Abstract

Heart failure is a common form of heart disease associated with progressive exercise intolerance and high risk of adverse clinical outcome events. The pathophysiology of chronic systolic heart failure is fundamentally determined by the failure of the circulatory system to deliver oxygen sufficient for metabolic needs, and it is best explained by a complex interplay between intrinsic abnormalities of ventricular pump function and extracardiac factors that limit oxygen use in metabolically active tissues. This brief review highlights the role of extracardiac factors (peripheral factors) that may impact exercise capacity in patients with chronic systolic heart failure. Reduced metabolic vasodilation limits delivery of available cardiac output reserve to skeletal muscle during exercise, and it is associated with reduced peak oxygen capacity. Abnormal substrate use in skeletal muscle due to reduced skeletal muscle mass, change in skeletal muscle fiber type, and mitochondrial dysfunction reduces work efficiency and submaximal exercise endurance capacity in patients with systolic heart failure. These extracardiac peripheral mechanisms of impaired exercise tolerance in chronic heart failure may be targets for novel therapeutic development in this patient population.

Entities:  

Keywords:  exercise; skeletal muscle; vasodilation

Mesh:

Year:  2018        PMID: 29461891     DOI: 10.1513/AnnalsATS.201710-789KV

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  5 in total

Review 1.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

Review 2.  The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases.

Authors:  Carmine Izzo; Paolo Vitillo; Paola Di Pietro; Valeria Visco; Andrea Strianese; Nicola Virtuoso; Michele Ciccarelli; Gennaro Galasso; Albino Carrizzo; Carmine Vecchione
Journal:  Life (Basel)       Date:  2021-01-15

3.  The impact of exercise training for chronic heart failure patients with cardiac resynchronization therapy: A systematic review and meta-analysis.

Authors:  Ran Guo; Yi Wen; Ying Xu; Ruikun Jia; Song Zou; Sijie Lu; Guobin Liu; Kaijun Cui
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

4.  Formulation and development of novel control release transdermal patches of carvedilol to improve bioavailability for the treatment of heart failure.

Authors:  Long Mo; Guijing Lu; Xiping Ou; Dongsheng Ouyang
Journal:  Saudi J Biol Sci       Date:  2021-08-31       Impact factor: 4.219

5.  Prognostic Impact of Hybrid Comprehensive Telerehabilitation Regarding Diastolic Dysfunction in Patients with Heart Failure with Reduced Ejection Fraction-Subanalysis of the TELEREH-HF Randomized Clinical Trial.

Authors:  Robert Irzmański; Renata Glowczynska; Maciej Banach; Dominika Szalewska; Ryszard Piotrowicz; Ilona Kowalik; Michael J Pencina; Wojciech Zareba; Piotr Orzechowski; Slawomir Pluta; Zbigniew Kalarus; Grzegorz Opolski; Ewa Piotrowicz
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.